Long-lived plasma cell differentiation
长寿命浆细胞分化
基本信息
- 批准号:7497525
- 负责人:
- 金额:$ 18.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-09-30 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAdoptive TransferAffinityAllelesAntibodiesAntibody AffinityAntigen PresentationAntigensAutoimmunityB cell differentiationB-LymphocytesBlast CellBone MarrowCD4 Positive T LymphocytesCell physiologyCell surfaceChickensConditionDNADifferentiation AntigensEnzyme-Linked Immunosorbent AssayFab ImmunoglobulinsFicollFrequenciesGamma globulinGene ExpressionGenerationsHaptensHelper-Inducer T-LymphocyteHomeostasisHumoral ImmunitiesIgG1Immune responseImmunizationIn VitroInvestigationLabelLeadLifeMeasuresMemoryMemory B-LymphocyteMolecularMusNitrophenolNumbersOutcomePTPRC genePathway interactionsPlasmaPlasma CellsPopulationReactive Plasma CellReceptors, Antigen, B-CellResidual stateRestReverse Transcriptase Polymerase Chain ReactionRoleSimulateSpleenSystemT-LymphocyteTNFSF5 geneTestingTimeTransgenesTransgenic OrganismsVaccinationWeekbasecongeniccytokineexperiencemouse modelpathogenplasma cell differentiationpreventrecombinasevaccine development
项目摘要
DESCRIPTION (provided by applicant): This proposal employs model mouse systems to address fundamental questions regarding the mechanism of long-term humoral immune response to pathogens. Long-lived plasma cells (PCs) in bone marrow (BM) are responsible for establishing protective life-long humoral immunity. Fully understanding differentiation mechanism of long-lived PC is critical for advanced vaccine development. We generated IA-B mice that lack MHC-II on about 95% of all B cells due to B-cell-restricted deletion of a loxP-flanked iab neo allele by the cd19cre Cre recombinase transgene. Upon immunization with a T cell dependent antigen, a small number of antigen-specific MHC-II+ B cells in IA-B mice dramatically expand to differentiate into GC B cells and make normal level of B220+ CD38+ memory B cells. However, these memory B cells lose MHC-II expression later because of on-going deletion of MHC-II by the cd19cre transgene, thus providing a unique system to study the role of MHC-II-dependent antigen presentation by memory B cells in humoral immunity. In association with loss of MHC-II on memory B cells, IA-B mice showed impaired affinity maturation in long-lived PCs. The hypothesis proposed here is that differentiation of memory B cells into long-lived PCs requires MHC-II dependent antigen presentation. The specific aims to test our hypothesis are: 1) determine the intrinsic requirement MHC-II in memory B cells function, by in vitro culture of purified VH transgenic MHC-II positive and MHC-II negative memory B cells in the presence of various stimulation conditions simulating T cell dependent or T cell independent stimulation and 2) determine the role of MHC-II in PC differentiation pathway of memory B cells, by adoptive transfer of purified VH transgenic MHC-II positive and MHC-II negative memory B cells into antigen-experienced or un-experienced recipient mice. These studies will establish whether MHC- II is required for memory function and whether T cells direct memory B cell differentiation to PC. This will form the basis for further investigations to elucidate the molecular mechanism and 'checkpoints' in the pathway of long-term humoral immunity. The outcome will be valuable for effective vaccine development as well as treating autoimmunity associated with PC differentiation of self-reactive memory B cells. Vaccination generates a small fraction of resting-memory B cells and long-lived plasma cells secreting protective antibody. This study will test whether differentiation of memory B cells to long-lived plasma cells requires MHC-II, a very important molecule for interacting with T cells. This study will further examine how this MHC-II molecule is important for memory B cell function in order to develop better vaccination.
描述(由申请人提供):本提案采用模型小鼠系统来解决关于病原体长期体液免疫反应机制的基本问题。骨髓中的长寿命浆细胞(pc)负责建立保护性终身体液免疫。充分了解长寿命PC的分化机制对疫苗的后期开发至关重要。由于cd19cre - Cre重组酶转基因导致B细胞限制性缺失loxp侧的iab - neo等位基因,我们产生了大约95%的B细胞缺乏MHC-II的IA-B小鼠。免疫T细胞依赖抗原后,IA-B小鼠体内少量抗原特异性MHC-II+ B细胞显著扩增分化为GC B细胞,并形成正常水平的B220+ CD38+记忆B细胞。然而,由于cd19cre转基因导致MHC-II持续缺失,这些记忆B细胞随后失去MHC-II表达,从而为研究记忆B细胞MHC-II依赖性抗原呈递在体液免疫中的作用提供了一个独特的系统。与记忆B细胞上MHC-II的缺失相关,IA-B小鼠在长寿命pc中表现出亲和力成熟受损。这里提出的假设是,记忆B细胞分化为长寿的pc细胞需要MHC-II依赖抗原呈递。检验我们假设的具体目的是:1)通过体外培养纯化的VH转基因MHC-II阳性和MHC-II阴性记忆B细胞,在模拟T细胞依赖或T细胞独立刺激的各种刺激条件下,确定MHC-II在记忆B细胞PC分化途径中的作用,确定记忆B细胞功能的内在需求。通过将纯化的VH转基因MHC-II阳性和MHC-II阴性记忆B细胞过继转移到抗原经历或未经历的受体小鼠中。这些研究将确定记忆功能是否需要MHC- II,以及T细胞是否直接将记忆B细胞分化为PC。这将为进一步研究阐明长期体液免疫途径中的分子机制和“检查点”奠定基础。该结果将对有效的疫苗开发以及治疗与自我反应记忆B细胞PC分化相关的自身免疫具有价值。疫苗接种产生一小部分静止记忆B细胞和长寿命浆细胞分泌保护性抗体。这项研究将测试记忆B细胞向长寿浆细胞的分化是否需要MHC-II, MHC-II是一种与T细胞相互作用的非常重要的分子。这项研究将进一步研究MHC-II分子对记忆B细胞功能的重要性,以开发更好的疫苗接种。
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHIKO SHIMODA其他文献
MICHIKO SHIMODA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHIKO SHIMODA', 18)}}的其他基金
Beta cell antigen presentation in models of Beta cell a*
Beta 细胞 a* 模型中的 Beta 细胞抗原呈递
- 批准号:
7038622 - 财政年份:2006
- 资助金额:
$ 18.03万 - 项目类别:
B cell antigen presentation in models of B cell a*
B 细胞 a* 模型中的 B 细胞抗原呈递
- 批准号:
7387451 - 财政年份:2006
- 资助金额:
$ 18.03万 - 项目类别:
B cell antigen presentation in models of B cell a*
B 细胞 a* 模型中的 B 细胞抗原呈递
- 批准号:
7192581 - 财政年份:2006
- 资助金额:
$ 18.03万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 18.03万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 18.03万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 18.03万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 18.03万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 18.03万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 18.03万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 18.03万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 18.03万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 18.03万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 18.03万 - 项目类别: